Analysts Offer Insights on Healthcare Companies: Lucid Diagnostics (LUCD), Edwards Lifesciences (EW) and BeiGene (BGNE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lucid Diagnostics (LUCD – Research Report), Edwards Lifesciences (EW – Research Report) and BeiGene (BGNE – Research Report) with bullish sentiments.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on LUCD:

• PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders
• PAVmed announces 1-for-15 reverse stock split
• Lucid Diagnostics price target lowered to $2.50 from $3 at BTIG
• Lucid Diagnostics expands executive team
• Lucid Diagnostics Provides Business Update and Third Quarter Financial Results